With the aim of further investigating the molecular evolution of beta defensin genes, after having analysed beta defensin 1 (DEFB1) in humans and several nonhuman primate species, we have studied the evolution of the beta defensin 2 gene (DEFB2), which codifies for a peptide with antimicrobial and chemoattractant activity, in humans and 16 primate species. We have found evidence of positive selection during the evolution of orthologous DEFB2 genes at two points on a phylogenetic tree relating these primates: during the divergence of the platyrrhines from the catarrhines and during the divergence of the Cercopithecidae from the Hylobatidae, Great Apes and humans. Furthermore, amino acid variations in Old World Monkeys seem to centre either on residues that are involved in oligomerisation in the human molecule, or that are conserved (40-80%) in beta-defensins in general. It is thus likely that these variations affect the biological function of the molecules and suggest that their synthesis and functional analysis might reveal interesting new information as to their role in innate immunity.
Introduction
The human beta defensin 2 (hBD2) was originally isolated from the skin of psoriatic patients, and was found to be constitutively expressed in foreskin, lung and trachea using the RT-PCR method. 1 Moreover, different authors have demonstrated that the hBD2 gene is upregulated upon inflammatory stimuli and its expression can subsequently be detected in many other tissues. [2] [3] [4] [5] The peptide has a broad antimicrobial activity ranging from Gram negative bacteria to yeasts. 1 It appears that hBD2 kills the pathogens via an electrostatic interaction between the oligomeric form with and a negatively charged microbial surface. 6 It has also been demonstrated that hBD2 shows a chemoattractant activity for immature dendritic cells and memory T cells. 7 Different genes coding for proteins involved, directly or indirectly, in the innate immune response have evolved rapidly by positive selection in response to changes in the pathogens to which the host is exposed. 8, 9 In this study, we investigate the molecular evolution of beta defensin 2 (DEFB2) gene in humans and 16 primate species. Comparisons among orthologous DEFB2 genes from several primate species give new insights into the evolution of the DEFB2 gene and the relation between the structure of the protein and its function.
Results
The alignment of nucleotide sequences of the primate DEFB2 coding region is shown in Table 1 . We calculated the number of synonymous nucleotide substitutions per synonymous site (dS) and the number of nonsynonymous nucleotide substitutions per nonsynonymous site (dN) by pairwise comparison among the 17 primate DEFB2 sequences (Table 2) . We restricted the analysis by studying only the sequence corresponding to the antimicrobially active, mature DEFB2. We hypothesised that only this region has been subject to a positive selection caused by direct interaction with pathogens and cellular receptors. We found that the dN value was higher than dS in several of the nucleotide sequence comparisons, indicating that a positive selection pressure acts at the level of this region (see Table 2 ).
In order to identify at which node the active portion of the molecule was altered under selection, we have computed the number of synonymous (bS) and nonsynonymous (bN) substitutions for each branch of the phylogenetic tree depicting the evolutionary relation among the primate species under investigation. For this analysis, we used a phylogenetic tree that is widely accepted by primatologists (Figure 1) . 10 Several branches showed greater values of bN than bS, but bN was significantly greater than bS in branch x (Z ¼ 2.56; Po0.05) and in branch y (Z ¼ 2.75; Po 0.05). These results indicate that positive selection has acted in the lineage leading to the clade including the homind and hylobatid families.
The deduced amino-acid sequences for the primate species are reported in Figure 2 . Humans and Great Apes (GA) showed identical amino-acid sequences, with the exception of a Gly 3 -Ser substitution in the N-terminal region seen only in P. troglodytes. The hylobatid sequences show very little variation with respect to the hBD2.
Three amino acid substitutions were observed in the N-terminal region of the active peptide, while only one conservative substitution was present in the C-terminal region. The Old World Monkeys (OWM, Cercopithecidae) are characterised by very similar amino acid sequences and showed a 71% average similarity with hBD2. In the Cercopithecidae we found variations such as Val To assess the functional implications of the observed amino-acid changes in primate defensins, the positions of affected residues were traced on the dimeric structure of hBD2 6 as shown in Figure 3 . A topological diagram, based on the hBD2 sequence, relating these residues to the secondary structure elements is also provided in Figure 2 . Amino-acid changes found in the gibbon (Hylobatidae) sequences, with respect to the human and GA sequences, are located exclusively at the N-terminus, preceding the short a-helical stretch. Cercopithecid sequence variations are more extensive and mainly involve the loops connecting the b-sheet, in particular between b-strands 2 and 3. However, variations seem to be clustered on one side of each monomeric structure (see Figure 3 ). They do not greatly affect the hydrophobicity of the molecules (the average per residue hydrophobicity according to the Eisenberg scale 11 varies from À0.2 in the PCR sequence to À0.22 in the human and À0.23 in the PPA sequences, respectively). The charge varies from +5/+7 (depending on the charge state of histidine) in the NWM sequence, to +6/+7 in the human or GA sequences, and to +7/+8 or +7/+9 in most OWM sequences.
The variable residues were also analysed in the context of positional conservation in beta defensin molecules in general, by aligning the 17 primate sequences reported here with the 17 primate beta defensins 1 sequences, 12 hBD3, and 14 bovid, one pig, nine rodent and eight avian beta defensin sequences obtained from the AMSDb antimicrobial sequences database, for a total of 67 sequences. The alignment of human and macaque DEFB2 sequences with selected sequences from other mammals is shown in Figure 4 .
Discussion
In this study, we have found evidence of positive selection during the evolution of orthologous DEFB2 genes. Evidence of positive selection was found in two points on the phylogenetic tree: during the divergence of the platyrrhines (NWM) from the catarrhines (OWM) and during the divergence of the Cercopithecidae from the Hylobatidae, Great Apes and humans ( Figure 1 ). To assess whether the variations at the amino-acid level could have functional implications, we analysed them in relation to the extensive data available for the structure and activity of the human peptide hBD2, whose structure is shown in Figure 3 . 6 The monomeric structure consists of a short N-terminal a-helix packed on top of a threestranded b-sheet. This typical b-defensin scaffold depends mainly on its disulfide linkages to provide for the correct folding; only two small residues are significantly buried (Ala 13 and Gly 29 in hBD-2), 13 and these are highly conserved among beta defensins in general (see Figure 4) . It is thus quite likely that all the primate DEFB2 molecules maintain this monomeric structure, Figure 3 . Dimerisation is stabilised by H-bonding interactions involving residues 5 and 13-17. 6 In the crystal structure, these dimers further oligomerise to form compact octamers via H-bonding interactions involving residues Gly 1 , Gly 3 and Asp 4 of the N-terminal loop of one monomer and residues Thr 7 and Lys 10 in the . Each monomer forms a three-stranded b-sheet with one helix flanking it at the N-terminus. The dimer is formed by interaction between strands b in each monomer, and involves residues Pro5 and Ala13 to Pro17 [6] . The approximate positions of a-carbons for residues involved in variations within primate sequences are indicated with spheres.
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helical stretch from the other monomer, in each dimer. It is conceivable that the variations observed in other primate DEFB2 sequences could affect dimerisation and/ or oligomerisation and thus also antimicrobial activity. Furthermore, human beta defensins have been shown to exert chemoattractant activity on T-lymphocytes and dendritic cells because of a specific interaction with the CCR6 receptor for the b-chemokine MIP-3a/CCL20. 7 For hBD2, it has been suggested that the N-terminal stretch from Asp 4 to Leu 9 resembles an equivalent Asp-CysCys-Leu (DCCL) stretch in the CCL20 important for receptor activation, while residues 14-24 and 36-40 provide a region that could bind the receptor in a similar manner to a groove present in CCL20.
14 Moreover, the overall distribution of basic residues, which is also likely important for chemokine binding, is similar in the two molecules. Thus, variations in the sequence might also affect this aspect of biological activity.
When the principal residue variations in the hylobatid, OWM or NWM DEFB2 sequences are displayed on the dimeric structure of hBD2, it is apparent that most variable residues cluster on one side of the monomeric structures (see Figure 3) . Furthermore, while residues involved in dimerisation (except His 16 -Leu in the macaques) are unaffected, the Gly -Arg substitution observed for some Cercopithecidae, involve those residues concerned with oligomerisation in the human peptide. The antimicrobial activity of the hBD2 has been proposed to occur via an electrostatic charge-based mechanism of membrane permeabilisation that involves accumulation and oligomerisation at the negatively charged bacterial surface. The observed N-terminal changes may thus imply that a particular form of oligomerisation has evolved specifically in apes and humans. These changes might also have some effect on interaction with the chemokine receptor: the hBD2 N-terminal stretch appears to be more similar to the functionally significant DCCL stretch of the CCL20 molecule (Asp 4 and Leu 9 are within the 8.5 Å distance observed for the DCCL motif 15 ) than that of the other primate sequences, where the Asp residue is shifted to position 1.
The other changes observed in CJA and the Cercopithecidae occur mainly at the level of the C-terminus, between residues 26 and 35 (see Figure 2) . The stretch 26-29 (QIGT) is quite conserved among different mammalian BD2 peptides (50-100% conservation depending on the residue, see Figure 4 ), and appears to have been maintained in the human sequence but to have shifted away from the more common form in these primates. Thus, Gln26 and Thr29, respectively, observed in 54 and 81% of mammalian BD2 peptides are present in the human, ape and gibbon sequences, but are replaced by a His and a Val, respectively, in the other primates. Furthermore, Pro at position 33 (also present in the CJA sequence) is also moderately conserved (40% of mammalian peptides), while Ser33 in the Cercopithecidae seems unique among mammals.
The significance of these variations at a functional level remains to be determined. Amino-acid substitutions Figure 4 Sequence alignment of mammalian beta defensins. The strictly conserved cysteines are highlighted in black, significantly conserved residues or residue types are highlighted in grey. The hBD2 numbering scheme is used.
in this region, among the different primate species, are not localised in DEFB2 regions that determine dimerisation in the human peptide, with the exception of the macaque sequences, where the His 16 -Val substitution occurs in the b2 sheet (see MMU, MFA and PPA in Figure  2 ). They also do not appear to affect the region that has been proposed to mimic the receptor recognition groove of CCL20, 14, 15 which is indicated as possibly important for DEFB2 chemoattractant activity. Conversely, variations at the N-terminus clearly affect the potential receptor activation motif (see above), and also the molecules' cationicity.
We have already investigated beta defensin 1 (DEFB1) gene evolution in humans and nonhuman primates. 12 While evidence of positive selection has been found for DEFB2 in nonhuman primates, we have not detected a positive selection during the evolution of DEFB1: in fact DEFB1 resulted more conserved than DEFB2 in all the nonhuman primate species analysed. The causes and consequences of these different conservation patterns remain to be explained.
In conclusion, we report that significant mutations have occurred during the evolution of primate DEFB2 gene, in response to positive selection for different products in humans, great apes and gibbons. Furthermore, amino-acid variations in OWMs seem to occur at residues that are involved in oligomerisation, as observed in the human sequence, and at residues that are moderately conserved in beta defensins in general. It is thus likely that these variations affect the biological function of the molecules and suggest that their synthesis and functional analysis might reveal interesting new information as to their role in innate immunity.
Materials and methods
Both exons of DEFB2 and short portions of their untranslated flanking and intronic regions have been investigated in 16 primate species for interspecific variability. We analysed three species of great apes (Pan troglodytes (PTR), Gorilla gorilla (GGO) and Pongo pygmaeus (PPY)), three species of the family Hylobatidae (Hylobates concolor (HCO), H. lar (HLA) and H. moloch (HMO)), nine species of Cercopithecidae (Macaca fascicularis (MFA), Macaca mulatta (MMU), Papio anubis (PPA), Cercopithecus aethiops (CAE), C. erythrogaster (CER), C. preussi (CPR), Presbytis cristata (PCR), P. obscurus (POB) and P. melalophos (PME)), and one platyrrhine species (Callithrix jacchus (CJA)).
Genomic DNAs were extracted from liver, bone and muscle tissues using the phenol/chloroform protocol. 16 DNA was also extracted from hairs using the Chelex 100 method. 17 Genomic amplification of orthologous DEFB2 genes was performed using primers designed on the basis of the published human sequence (GenBank accession number AF071216). For the first exon, the forward primer was 5 0 -CTGAATTCTAACCTCTGTAAT-GAGCAT-3 0 and the reverse primer was 5 0 -AGA-GAACTTCTACGCCATTCTTCC-3 0 . For the second exon, the forward primer was 5 0 -CTGGAGAGCA-GAAAAAGGTGTTT-3 0 and the reverse primer was 5 0 -TGTTTTTCCAACATGAGTTTTGAGTT-3 0 . For both the exons 45 cycles of PCR were performed using the GeneAmp PCR System 9700 (Applera Genomics Foster City, CA, USA) with 1 U of Taq Gold (Applera Genomics) and an annealing temperature of 551C. The pGEM-T Easy Vector System (Promega Corporation, Madison, WI, USA) was used for cloning of PCR products. Recombinant plasmids were propagated in DH5-a bacteria. A total of 10 recombinants were chosen and plasmids extracted using standard protocols 16 in order to exclude the possibility of obtaining sequences from paralogous genes or pseudogenes eventually present in the genome of the species studied. DNA sequencing of the p-GEM plasmids was performed using the BigDye Terminator Cycle Sequencing Ready Reaction Kit v. 2.0 (Applera Genomics). DNA sequences were detected and analysed on an automated ABI Prism 3100 Genetic Analyser (Applera Genomics).
Multiple alignments of the nucleotide and amino-acid sequences were performed using the program CLUSTAL X. 18 Pairwise comparisons between nucleotide sequences were performed to investigate the extent of evolutionary constraint at the amino-acid level in the molecule. The number of synonymous nucleotide substitutions per synonymous site (dS) and the number of nonsynonymous nucleotide substitutions per nonsynonymous site (dN) between each pair of orthologous sequences were computed following the Nei and Gojobori's method, 19 using the Mega 2.0 software. 20 Finally, to investigate the possibility of the occurance of positive selection and to identify the evolutionary lineages in which it would have occurred, the number of synonymous (bS) and nonsynonymous (bN) substitutions per site was estimated from the pairwise distances for each tree branch. 21 The structure of hBD2 was obtained from the PDB database (entries 1FD3 and 1FD4). 6 A positional residue frequency analysis for beta defensin sequences was performed on 67 sequences obtained from the AMSDb antimicrobial sequences database (www.bbcm.units. it/Btossi/), using the conserved cysteines for correct alignment, to allow an estimate of residue conservation in key positions.
